Share

Pfizer posts earnings beat but doubts remain about organic growth: Analyst

Barbara Ryan, Barbara Ryan Advisors, sifts through Pfizer's quarterly results and weighs in on ways the pharma giant can grow.
03:25
Tue, Oct 31 20177:46 AM EDT